KaSARi: a national framework for standardized, automated, and predictive radiotherapy in Finland

Authors

  • Jan Seppälä Department of Radiotherapy, Kuopio University Hospital, Kuopio, Finland https://orcid.org/0000-0002-0922-329X
  • Maria Tengström Department of Radiotherapy, Kuopio University Hospital, Kuopio, Finland https://orcid.org/0000-0002-4024-1904
  • Henri Korkalainen Department of Radiotherapy, Kuopio University Hospital, Kuopio, Finland; Department of Techincal Physics, University of Eastern Finland, Kuopio, Finland https://orcid.org/0000-0002-4686-6112
  • Tuomas Virén Department of Radiotherapy, Kuopio University Hospital, Kuopio, Finland https://orcid.org/0000-0002-7685-7911
  • Juuso TJ Honkanen Department of Radiotherapy, Kuopio University Hospital, Kuopio, Finland https://orcid.org/0000-0002-9150-9253
  • Juha Nikkinen Department of Radiotherapy, Research Unit of Health Sciences and Technology, Oulu University Hospital, University of Oulu, Oulu, Finland https://orcid.org/0000-0001-6355-3444
  • Kaisa Lehtiö Department of Radiotherapy, Research Unit of Health Sciences and Technology, Oulu University Hospital, University of Oulu, Oulu, Finland
  • Annika Ålgars Department of Oncology and Radiotherapy, Turku University Hospital and University of Turku, Turku, Finland https://orcid.org/0000-0002-9841-1881
  • Jani Keyriläinen Department of Oncology and Radiotherapy, Turku University Hospital and University of Turku, Turku, Finland https://orcid.org/0000-0001-7504-4460
  • Sami Suilamo Department of Oncology and Radiotherapy, Turku University Hospital and University of Turku, Turku, Finland
  • Heidi Nurmi Department of Oncology and Radiotherapy, Turku University Hospital and University of Turku, Turku, Finland https://orcid.org/0009-0009-0008-6522
  • Tanja Skyttä Department of Oncology, Tampere University Hospital, Wellbeing Services County of Pirkanmaa, Tampere, Finland
  • Eeva Boman Department of Oncology, Tampere University Hospital, Wellbeing Services County of Pirkanmaa, Tampere, Finland; Department of Clinical Physiology, Nuclear Medicine and Medical Physics, Tampere University Hospital, Wellbeing Services County of Pirkanmaa,Tampere, Finland https://orcid.org/0000-0001-6492-2475
  • Tero Vatanen Cancer Centre, North Carelia Central Hospital, Joensuu, Finland
  • Liisa Sailas Cancer Centre, North Carelia Central Hospital, Joensuu, Finland
  • Ulla-Mari Arkko Cancer Centre, North Carelia Central Hospital, Joensuu, Finland
  • Kristiina Vuolukka Department of Radiotherapy and Oncology, Wellbeing Services County of Central Finland, Jyväskylä, Finland https://orcid.org/0000-0001-9067-0566
  • Tuomas Koivumäki Department of Radiotherapy and Oncology, Wellbeing Services County of Central Finland, Jyväskylä, Finland https://orcid.org/0000-0001-8673-7000
  • Tiina Metsäharju Department of Radiotherapy, Kuopio University Hospital, Kuopio, Finland
  • Timo Voivalin Department of Radiotherapy, Kuopio University Hospital, Kuopio, Finland
  • Janne Heikkilä Department of Radiotherapy, Kuopio University Hospital, Kuopio, Finland https://orcid.org/0000-0003-1767-5779

DOI:

https://doi.org/10.2340/1651-226X.2026.45682

Keywords:

Radiotherapy, Real-world data, Artificial Intelligence, Toxicity, Quality of Life

Abstract

Background and purpose: National radiotherapy (RT) data infrastructures are emerging to support treatment quality assurance and outcome research. However, prospective nationwide integration of full DICOM-RT data with toxicity and patient-reported outcome measures (PROMs) remains uncommon. KaSARi (Key advances in Standardizing, Automating, and predicting Risks in RT) was established to create national research infrastructure for prospective RT data collection and integration in Finland.
Materials and methods: KaSARi is a prospective, consent-based multicenter cohort infrastructure involving Finnish university and central hospitals. All adult patients receiving RT are eligible. DICOM-RT datasets from treatment planning and oncology information systems are linked to clinician-graded toxicity, PROMs and relevant clinical variables. The infrastructure builds on previously validated multi-institutional DICOM workflows and follows FAIR (Findable, Accessible, Interoperable, Reusable) data principles. Predefined work packages support data harmonization, scalable data processing and enable downstream applications such as AI-based segmentation, dose prediction, and outcome modeling.
Results: Patient recruitment started in May 2025. By February 2026, 221 patients had been enrolled at the coordinating center, initially including breast cancer patients and subsequently expanding to all RT indications. Recruitment at a second center began in November 2025, with 37 patients enrolled. The infrastructure is projected to include approximately 29,000 patients over 15 years. Integration of dosimetric, clinical and PROM data is progressing through a phased national implementation as additional centers join the network.
Interpretation: KaSARi represents a national infrastructure prospectively integrating full DICOM-RT datasets with clinician-graded toxicity and PROMs across all RT indications within a unified research protocol. The study provides a foundation for nationwide outcome modeling, harmonization of RT practices and development and validation of data-driven AI-based methods.

Downloads

Download data is not yet available.

References

Lustberg T, van Soest J, Jochems A, Deist T, van Wijk Y, Walsh S, et al. Big Data in radiation therapy: challenges and opportunities. Br J Radiol. 2017;90:20160689. DOI: https://doi.org/10.1259/bjr.20160689

Guzene L, Beddok A, Nioche C, Modzelewski R, Loiseau C, Salleron J, et al. Assessing interobserver variability in the delineation of structures in radiation oncology: a systematic review. Int J Radiat Oncol Biol Phys. 2023;115:1047–60. DOI: https://doi.org/10.1016/j.ijrobp.2022.11.021

Patrick HM, Souhami L, Kildea J. Reduction of inter-observer contouring variability in daily clinical practice through a retrospective, evidence-based intervention. Acta Oncol. 2021;60:229–36. DOI: https://doi.org/10.1080/0284186X.2020.1825801

Batumalai V, Jameson MG, Forstner DF, Vial P, Holloway LC. How important is dosimetrist experience for intensity modulated radiation therapy? A comparative analysis of a head and neck case. Pract Radiat Oncol. 2013;3:e99–106. DOI: https://doi.org/10.1016/j.prro.2012.06.009

Nelms BE, Robinson G, Markham J, Velasco K, Boyd S, Narayan S, et al. Variation in external beam treatment plan quality: an inter-institutional study of planners and planning systems. Pract Radiat Oncol. 2012;2:296–305. DOI: https://doi.org/10.1016/j.prro.2011.11.012

Bentzen SM, Constine LS, Deasy JO, Eisbruch A, Jackson A, Marks LB, et al. Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues. Int J Radiat Oncol Biol Phys. 2010;76:S3–9. DOI: https://doi.org/10.1016/j.ijrobp.2009.09.040

Puri T. Voxel-based dose-toxicity modeling for predicting post-radiotherapy toxicity: a critical perspective. J Clin Med. 2025;14:7248. DOI: https://doi.org/10.3390/jcm14207248

Krogh SL, Brink C, Lorenzen EL, Samsøe E, Vogelius IR, Zukauskaite R, et al. A national repository of complete radiotherapy plans: design, results, and experiences. Acta Oncol. 2023;62:1161–8. DOI: https://doi.org/10.1080/0284186X.2023.2270143

Olsson CE, Krogh SL, Karlsson M, Eriksen JG, Björk-Eriksson T, Grau C, et al. Danish and Swedish National data collections for cancer – solutions for radiotherapy. Clin Oncol (R Coll Radiol). 2025;37:103657. DOI: https://doi.org/10.1016/j.clon.2024.10.009

Finnish Cancer Center (FICAN). [cited 2026 Mar 10]. Available from: https://fican.fi/

Finnish Cancer Registry. [cited 2026 Mar 10]. Available from: https://cancerregistry.fi/information/

Pukkala E, Engholm G, Højsgaard Schmidt LK, Storm H, Khan S, Lambe M, et al. Nordic Cancer Registries – an overview of their procedures and data comparability. Acta Oncol. 2018;57:440–55. DOI: https://doi.org/10.1080/0284186X.2017.1407039

Mayo CS, Moran JM, Bosch W, Xiao Y, McNutt T, Popple R, et al. American Association of Physicists in Medicine Task Group 263: standardizing nomenclatures in radiation oncology. Int J Radiat Oncol Biol Phys. 2018;100:1057–66. DOI: https://doi.org/10.1016/j.ijrobp.2017.12.013

Heikkilä J, Virsunen H, Voutilainen L, Vuolukka K, Nevantaus A, Haatanen M, et al. Implementing an automated target delineation service in a multi-institutional environment in Finland. Radiother Oncol. 2019;133(Suppl 1):S602. (Abstract PO-1104). DOI: https://doi.org/10.1016/S0167-8140(19)31524-5

Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–76. DOI: https://doi.org/10.1093/jnci/85.5.365

Nielsen M, Linaa MB, Hansen VN, Kaplan LP, Lund MD, Nielsen MS, et al. A comprehensive national audit of radiotherapy retreatment numbers, sites and indications. Acta Oncol. 2025;64:872–8. DOI: https://doi.org/10.2340/1651-226X.2025.43825

Peltola MK, Lehikoinen JS, Sippola LT, Saarilahti K, Mäkitie AA. A novel digital patient-reported outcome platform for head and neck oncology patients – a pilot study. Clin Med Insights Ear Nose Throat. 2016;9:1–6. DOI: https://doi.org/10.4137/CMENT.S40219

Downloads

Published

2026-05-18

How to Cite

Seppälä, J., Tengström, M., Korkalainen, H., Virén, T., Honkanen, J. T., Nikkinen, J., … Heikkilä , J. (2026). KaSARi: a national framework for standardized, automated, and predictive radiotherapy in Finland . Acta Oncologica, 65, 430–436. https://doi.org/10.2340/1651-226X.2026.45682

Issue

Section

Original article

Categories